Dawson NA - Search Results

1

Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review.

Byrd JC, Edenfield WJ, Shields DJ, Dawson NA. Byrd JC, et al. Among authors: dawson na. J Clin Oncol. 1995 Jul;13(7):1800-16. doi: 10.1200/JCO.1995.13.7.1800. J Clin Oncol. 1995. PMID: 7602369 Review.

2

Extramedullary myeloid cell tumors in myelodysplastic-syndromes: not a true indication of impending acute myeloid leukemia.

Byrd JC, Edenfield WJ, Dow NS, Aylesworth C, Dawson N. Byrd JC, et al. Leuk Lymphoma. 1996 Mar;21(1-2):153-9. doi: 10.3109/10428199609067593. Leuk Lymphoma. 1996. PMID: 8907283 Review.

3

Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells.

Byrd JC, Shinn C, Ravi R, Willis CR, Waselenko JK, Flinn IW, Dawson NA, Grever MR. Byrd JC, et al. Among authors: dawson na. Blood. 1999 Aug 15;94(4):1401-8. Blood. 1999. PMID: 10438728 Free article.

4

Chemotherapy of disseminated Merkel-cell carcinoma.

Redmond J 3rd, Perry J, Sowray P, Vukelja SJ, Dawson N. Redmond J 3rd, et al. Am J Clin Oncol. 1991 Aug;14(4):305-7. doi: 10.1097/00000421-199108000-00006. Am J Clin Oncol. 1991. PMID: 1862761

5

Apples and oranges: building a consensus for standardized eligibility criteria and end points in prostate cancer clinical trials.

Dawson NA. Dawson NA. J Clin Oncol. 1998 Oct;16(10):3398-405. doi: 10.1200/JCO.1998.16.10.3398. J Clin Oncol. 1998. PMID: 9779719

6

Clinical predictors of response in metastatic germ cell tumors.

Taylor G, Perry DJ, Knight RD, Dawson NA, Skoog SJ, McLeod DG. Taylor G, et al. Among authors: dawson na. Cancer. 1988 Jul 1;62(1):217-21. doi: 10.1002/1097-0142(19880701)62:1<217::aid-cncr2820620133>3.0.co;2-l. Cancer. 1988. PMID: 2454719

7

Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921.

Hussain M, Tangen CM, Thompson IM Jr, Swanson GP, Wood DP, Sakr W, Dawson NA, Haas NB, Flaig TW, Dorff TB, Lin DW, Crawford ED, Quinn DI, Vogelzang NJ, Glode LM. Hussain M, et al. Among authors: dawson na. J Clin Oncol. 2018 May 20;36(15):1498-1504. doi: 10.1200/JCO.2017.76.4126. Epub 2018 Apr 6. J Clin Oncol. 2018. PMID: 29624463 Free PMC article. Clinical Trial.

8

Response criteria in prostatic carcinoma.

Dawson NA. Dawson NA. Semin Oncol. 1999 Apr;26(2):174-84. Semin Oncol. 1999. PMID: 10597728 Review.

9

Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer.

Dawson NA, Figg WD, Cooper MR, Sartor O, Bergan RC, Senderowicz AM, Steinberg SM, Tompkins A, Weinberger B, Sausville EA, Reed E, Myers CE. Dawson NA, et al. J Clin Oncol. 1997 Apr;15(4):1470-7. doi: 10.1200/JCO.1997.15.4.1470. J Clin Oncol. 1997. PMID: 9193342 Clinical Trial.

10

Trimetrexate in untreated and previously treated patients with metastatic breast cancer: a Cancer and Leukemia Group B study.

Dawson NA, Costanza ME, Korzun AH, Clamon GH, Pollak M, Vogelzang NJ, Carey RW, Norton L. Dawson NA, et al. Med Pediatr Oncol. 1991;19(4):283-8. doi: 10.1002/mpo.2950190413. Med Pediatr Oncol. 1991. PMID: 1829134 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page